Laboratory services leader adds pharma veteran to board. Lab services giant LabCorp appointed Novartis US President Victor ...

J&J is predicting 2026 revenues will be between $99.5 billion and $100.5 billion, up from just over $94 billion in 2025.

Amazon has become the latest tech company to introduce an AI-powered assistant that is designed to provide health guidance ...

A year after President Trump signed an executive order for the US to withdraw from the World Health Organization (WHO), the ...

Roche's Gazyvaro, a drug that can restore kidney function in people living with lupus nephritis, has been cleared for use by the NHS in England and Wales. Around 12,000 people with kidney disease ...

Medicines for obesity, diabetes, rare diseases, cancer, and women's health feature among Clarivate's annual round-up of 11 Drugs to Watch this year, but two of them far outstrip the others in sales ...

Shares in ImmunityBio rose sharply after the company said it has agreed a path with the FDA that will allow it to refile for ...

Tickets are on sale for the 40th anniversary of the PM Awards! Book now and join us on Friday 20 th March 2026 at the JW ...

The European Commission has approved Otsuka's Dawnzera for the prevention of recurrent attacks in rare disease hereditary ...

In a wide-ranging sit down during JP Morgan Week in San Francisco, Astellas' chief strategy officer Adam Pearson walked ...

Hopstem has already completed phase 1 testing of hNPC01 in China, with encouraging results, and says it has now reached ...

That closes out our agency round-up for last year, but stay tuned for our other hires round-ups and remember, you can send ...